Novartis India's Q1 financials show mixed results, with 'Hold' call from MarketsMOJO

May 10 2024 06:30 PM IST
share
Share Via
Novartis India, a smallcap pharmaceutical company, reported a 57.20% increase in Profit Before Tax (PBT) for the quarter ending March 2024. However, Profit After Tax (PAT) fell by -41.3% YoY, with a high reliance on non-business income. Earnings per Share (EPS) also declined, resulting in a flat financial performance and a 'Hold' call by MarketsMojo.

Novartis India, a smallcap pharmaceutical company, recently announced its financial results for the quarter ending March 2024. The company's stock has been given a 'Hold' call by MarketsMOJO.

According to the financials, Novartis India's Profit Before Tax (PBT) has shown a significant growth of 57.20% Year on Year (YoY), reaching Rs 10.91 crore. This is a positive trend for the company in the near term.

However, the company's Profit After Tax (PAT) has fallen by -41.3% YoY, standing at Rs 14.68 crore. This is a concerning trend for the company's profitability in the near term. Additionally, the company's Non Operating Income is 48.85% of its PBT, indicating a high reliance on non-business activities for income.

Furthermore, Novartis India's Earnings per Share (EPS) for the quarter is at its lowest in the last five quarters, standing at Rs 5.95. This decline in profitability is not favorable for the company's shareholders.

Overall, Novartis India's financial performance for the quarter ending March 2024 has been flat, with a score of 1 out of 14. Investors are advised to hold their positions in the company's stock, as per MarketsMOJO's recommendation.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Why is Novartis India falling/rising?
Dec 05 2025 12:56 AM IST
share
Share Via
Why is Novartis India falling/rising?
Nov 06 2025 10:05 PM IST
share
Share Via
Is Novartis India overvalued or undervalued?
Nov 05 2025 08:06 AM IST
share
Share Via
Is Novartis India overvalued or undervalued?
Nov 03 2025 08:04 AM IST
share
Share Via
Is Novartis India overvalued or undervalued?
Nov 02 2025 08:04 AM IST
share
Share Via
Is Novartis India overvalued or undervalued?
Nov 01 2025 08:05 AM IST
share
Share Via
Most Read
Why is Premium Plast falling/rising?
1 hour ago
share
Share Via
Why is Bikewo Green falling/rising?
1 hour ago
share
Share Via
Why is Quest Laborato. falling/rising?
1 hour ago
share
Share Via
Why is Kataria Indust. falling/rising?
1 hour ago
share
Share Via
Why is Vishwas Agri falling/rising?
1 hour ago
share
Share Via